239 results
DEFA14A
TXMD
TherapeuticsMD Inc
17 May 23
Additional proxy soliciting materials
5:05pm
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting … , if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials.
Fee
8-K
q7el2e12satbvb
21 Apr 23
Other Events
5:14pm
8-K
EX-10.2
j0r2 ere61qptp6o
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-10.1
bnuapojn
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
D
28am0jie
14 Nov 22
$7.00 mm in equity / options / securities to be acquired, sold $7.00 mm, 6 investors
4:51pm
8-K
EX-10.2
vf4vn
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
51ka4u2 snvs
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
D
bnd 0nnboatjyoq0kd
17 Oct 22
$7.00 mm in equity / options / securities to be acquired, sold $7.00 mm, 6 investors
4:36pm
8-K
EX-10.2
9kx ntmfj5jr0qtuius
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.1
ac3z83tp pzr
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am